MORPHOSYS US INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Income

—

Filings

Unique Clients

Active Period

2020–2022

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2022	—	1	1
2021	—	5	1
2020	—	5	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
MORPHOSYS US INC.	—	11	2020–2022

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
No government targets were reported in these filings.

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	1

Source: Senate LDA

MORPHOSYS US INC. — Lobbying Disclosure | Poliscope